Moreover, Suriben et al. [33] recently demonstrated that suppression of GFRAL signalling with the therapeutic antagonistic monoclonal antibody 3P10 may reverse GDF15-induced excessive lipid oxidation and prevent cancer-related cachexia. Here, GDF15 is linked to cancer.